共 50 条
- [41] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
- [46] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
- [48] A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2019, 11
- [49] Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease PLOS ONE, 2018, 13 (11):
- [50] Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review JGH OPEN, 2020, 4 (05): : 808 - 817